Close
Nordic 9Nordic 9

Imperagen (private company)

United Kingdom imperagen.com
See something wrong or missing? Let us know
Offices:Manchester
Industry:BiotechHealth services
Business model:B2B

Imperagen is a British startup developing an ultra-fast enzyme engineering platform, with the longer-term aim of developing enzymes for applications ranging from laboratory tools to enzyme replacement therapies and drug delivery systems.

Investors: we tracked 2 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 4.25M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Imperagen

Name Criteria
Denmark Acesion Pharma
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Norway APIM Therapeutics
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Germany Biomes
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Spain DeepuII
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Finland FinnAdvance
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom iLoF
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Novai
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Denmark Octarine Bio
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Austria Sarcura
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Switzerland Scailyte
48%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one vc investor: found 2
  • Total raised in a similar range: 1M - 5M USD
Top